Eisai’s Oral Aloxi Approved For Chemo-related Nausea/Vomiting
This article was originally published in The Pink Sheet Daily
Executive Summary
Antiemetic gained through MGI acquisition competes with oral therapies Zofran from GSK and Roche’s Kytril .